Ermira Kuko-Samara
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Increased gene therapy efficacy through the use of extended half-life clotting factors.
Journal: Blood advances
Published: October 24, 2025
Long-Term Functional Correction of Pompe Disease and Increased α-Glucosidase Expression after Gene Therapy with Novel Combinations of Muscle-Targeted Transcriptional Cis-Regulatory Elements.
Journal: Human gene therapy
Published: July 18, 2025
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 02, 2022
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons.
Journal: Molecular therapy. Nucleic acids
Published: August 31, 2019
Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 21, 2015
Next-generation muscle-directed gene therapy by in silico vector design.
Journal: Nature communications
Published: November 15, 2015
Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 16, 2014
Liver-specific transcriptional modules identified by genome-wide in silico analysis enable efficient gene therapy in mice and non-human primates.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 04, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026